Ct calcium scoring in detail, definition, principle , technique, equipment required, protocol , and all steps in detail

Reading File
Finding Sources
Finding Sources
Searching Images

CT calcium scoring coronary artery calcification technique

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Loading Image
Loading Image
I now have comprehensive material from multiple authoritative textbooks. Let me compile the full detailed response.

CT Calcium Scoring (Coronary Artery Calcium Scoring — CAC)


1. Definition

CT calcium scoring (also called Coronary Artery Calcium scoring, CAC scoring) is the simplest application of cardiac CT. It is a non-contrast, ECG-gated CT scan that detects and quantifies calcified atherosclerotic plaques in the coronary arteries. The result is expressed as a numerical score — most commonly the Agatston score — that reflects the total burden of coronary artery calcification (CAC) and is used as a surrogate marker for atherosclerotic plaque burden and cardiovascular risk.
"Coronary calcium is an indicator of the burden of atherosclerotic plaque, although there is no correlation of the amount of local coronary calcium with the physiologic or anatomic significance of an underlying coronary stenosis." — Goldman-Cecil Medicine

2. Principle

Pathophysiological Basis

  • Calcification in the coronary arteries occurs almost exclusively in the setting of coronary atherosclerosis (with the exception of advanced chronic kidney disease).
  • As the amount of coronary calcium roughly correlates to the extent of atherosclerotic plaque, its detection and quantification allows risk stratification.
  • Most patients with acute coronary syndrome (ACS) have coronary calcium, and their calcium burden is substantially greater than in age- and sex-matched controls without CAD.
  • Importantly, coronary calcification is not related to plaque stability/instability and is only weakly related to the severity of luminal stenosis — i.e., a heavily calcified plaque may not be obstructive.

Physical Principle

  • CT acquires images by passing a thin X-ray beam through the body at multiple angles. X-ray transmission measurements are digitized into pixels — each assigned a value in Hounsfield units (HU), referenced to water (0 HU).
  • Calcium is highly attenuating and appears bright white on non-contrast CT, even without contrast enhancement.
  • A coronary lesion is defined as calcium when CT density is ≥ 130 HU with an area of ≥ 1 mm².

Agatston Score Calculation

Agatston score formula and CT image
The Agatston score is calculated for each individual calcified lesion:
HU RangeDensity Weight Factor
130–199 HU1
200–299 HU2
300–399 HU3
≥ 400 HU4
Plaque score = lesion area (mm²) × density weight factor
Total Agatston score = sum of all individual plaque scores across all coronary arteries
  • The Agatston score corresponds to each coronary lesion's calcium area multiplied by the maximal CT attenuation value, then summed for the entire coronary tree.
  • Less commonly, volume score (mm³) and calcium mass score (mg) are also used.

3. Score Interpretation / Categories

Agatston ScoreCategoryInterpretation
0AbsentNo detectable calcification; very low risk
1–10MinimalTrace calcification
10–100MildMild plaque burden
100–400ModerateModerate plaque burden
> 400SevereExtensive plaque; high cardiovascular risk
  • Scores are age, sex, and race dependent; they are normalized and reported as percentile scores against population databases.
  • Overall 15-year mortality rates in asymptomatic patients range from 3 to 28% for CAC scores from 0 to ≥ 1000.
  • A CAC score of 0 (zero) is associated with excellent prognosis; future cardiac events are highly unlikely.
  • CAC adds prognostic information independently of standard risk factors (Framingham risk score).

4. Equipment Required

CT Scanner

  • Multi-detector CT (MDCT) scanner — the standard platform today
    • Minimum: 16-slice MDCT; optimal: 64-slice or higher
    • Modern scanners: 128–640 slice systems (dual-source CT, wide-detector CT)
  • Electron Beam CT (EBCT) — the original scanner used for CAC scoring (now largely replaced by MDCT)
    • Advantages of EBCT: very fast acquisition, less cardiac motion artefact
    • Disadvantage: less widely available

ECG Synchronization

  • ECG gating hardware — mandatory for cardiac motion suppression
    • Prospective ECG triggering is standard for CAC scoring (triggers acquisition at a fixed phase of the cardiac cycle, typically mid-diastole)
    • Reduces motion blur, minimises radiation dose

Other Required Equipment

  • ECG electrodes and monitoring leads (3 or 4 lead setup)
  • Cardiac calcium scoring post-processing software (e.g., Syngo.via [Siemens], AW workstation [GE], Extended Brilliance Workspace [Philips])
  • Software automatically identifies lesions ≥ 130 HU and calculates per-vessel and total Agatston scores with color-coded overlays

5. Indications

CAC scoring is appropriate in:
  • Asymptomatic adults at intermediate cardiovascular risk (10–20% 10-year event risk) — most validated indication, can "upgrade" or "downgrade" risk category
  • Asymptomatic patients at low risk with a family history of premature ischaemic heart disease
  • Patients where statin therapy decision is uncertain after clinical risk assessment
  • Not indicated in symptomatic patients (a negative CAC score does not exclude obstructive CAD in young or symptomatic patients)

6. Contraindications / Limitations

  • Symptomatic patients — a zero CAC score does not reliably exclude CAD (especially in young patients with non-calcified soft plaques)
  • Patients with known CAD or prior revascularisation — rarely changes management
  • Already low-risk or already high-risk patients — adds limited incremental value (a very high CAC may prompt stress testing)
  • Pregnancy — ionising radiation contraindicated
  • Advanced CKD — calcification may occur without atherosclerosis, reducing specificity
  • Irregular heart rhythm (AF) — impairs ECG gating, though modern software can compensate

7. Patient Preparation

  1. No iodinated contrast is required — this is a plain (non-contrast) scan
  2. Patient should avoid caffeine and smoking for several hours before the scan (may affect heart rate)
  3. Ideally, heart rate should be below 65–70 bpm for adequate gating, though CAC is more forgiving than CTA
  4. Beta-blockers may be given to lower heart rate if needed (more critical for CT angiography)
  5. Explain the procedure; no special fasting required (unlike contrast studies)
  6. Remove metallic objects from the chest area
  7. Attach ECG electrodes to the chest

8. Scan Protocol — Step by Step

Step 1: Scout / Topogram

  • Acquire a low-dose AP scout image of the chest
  • Used to define the scan range: from the carina (level of the tracheal bifurcation) down to the diaphragm, encompassing the entire heart

Step 2: ECG Electrode Placement and Monitoring

  • Attach 3–4 lead ECG electrodes to the patient's chest
  • Verify a clean ECG signal on the console
  • Prospective ECG triggering: acquisition is triggered at ~70–75% of the R–R interval (mid-diastole), when the heart is most still

Step 3: Breath-Hold Instruction

  • Instruct the patient to take a moderate breath-hold (not a forced deep inspiration) during acquisition
  • Typically 10–15 seconds

Step 4: Acquisition Parameters

ParameterTypical Value
Tube voltage (kVp)120 kVp (standard); 100 kVp for smaller patients
Tube current (mAs)50–100 mAs (low dose)
Slice thickness2.5–3 mm (standard for Agatston); reconstructed at 2.5 mm
Rotation time0.35–0.5 sec
Gating modeProspective ECG triggering
Reconstruction kernelMedium-smooth (e.g., B35f or similar)
Field of view (FOV)Heart-centred, ~25 cm
Matrix512 × 512
Scan directionCranio-caudal
Note: Slice thickness of 2.5–3 mm is standardised for Agatston scoring; thinner slices (used in CT angiography) do not yield directly comparable Agatston scores.

Step 5: Radiation Dose

  • Radiation dose is intentionally very low: approximately 1–2 mSv (comparable to a few months of background radiation)
  • Prospective gating significantly reduces dose compared to retrospective spiral acquisition

9. Image Reconstruction and Post-Processing

Step 1: Reconstruction

  • Images are reconstructed at 2.5 mm slice thickness with a medium-smooth kernel
  • Iterative reconstruction algorithms (e.g., SAFIRE, iDose, ASIR) reduce image noise — allow diagnostic quality even at low dose

Step 2: Transfer to Calcium Scoring Workstation

  • DICOM images are sent to dedicated cardiac scoring software

Step 3: Automated Lesion Detection

  • Software automatically identifies all foci ≥ 130 HU with area ≥ 1 mm²
  • Highlights them with color-coded overlays by coronary territory (e.g., LM = cyan, LAD = green, RCA = red, LCx = blue)
  • Assigns density weight factors (1–4) based on peak HU
Color-coded CAC scoring software output showing per-vessel Agatston scores
Example: LM = 2, RCA = 341, LAD = 354, LCx = 128 → Total Agatston = 836 (severe)

Step 4: Manual Review and Editing

  • The radiologist/technologist reviews each detected lesion
  • False positives must be excluded: papillary muscle calcification, mitral/aortic valve calcifications, sternal wires, pericardial calcification — these are NOT coronary and must be deleted from the ROI
  • False negatives from automated algorithms can occur in extensive calcification

Step 5: Per-Vessel Score Reporting

  • Scores are reported per vessel (LM, LAD, LCx, RCA) and as a total
  • Volume (mm³) is also calculated as a secondary metric
  • Total score is compared to age/sex/race-matched percentile tables and the patient is placed in a risk percentile

10. CT Images — Grades of CAC

Four non-contrast axial CT scans showing CAC-DRS 0 (no calcium) through severe calcification
Panel (a): CAC-DRS 0 — no calcium. Panel (b): minimal punctate calcium. Panels (c) and (d): significant progressive calcification.

11. Reporting

A complete CAC report includes:
  1. Total Agatston score
  2. Per-vessel Agatston scores (LM, LAD, LCx, RCA)
  3. Volume score (total, mm³)
  4. Age/sex/race-adjusted percentile
  5. Risk category (absent / minimal / mild / moderate / severe)
  6. Incidental findings on the scan (lung nodules, pleural effusion, aortic aneurysm, etc.) — important added value of every CAC scan
  7. Clinical correlation and recommendation (e.g., discuss with clinician regarding statin initiation)

12. Clinical Utility

  • Primary prevention risk stratification: CAC is currently the strongest imaging-based predictor of future MI and cardiac death in asymptomatic patients
  • Useful to reclassify intermediate-risk patients — a zero score may defer statin therapy; a high score may escalate it
  • High scores may prompt stress testing even in otherwise low-symptom patients
  • CAC can also be acquired as a by-product during hybrid SPECT/CT or PET/CT scans
  • CAC scoring does not require contrast, making it suitable for patients with renal insufficiency or contrast allergy when coronary CTA would be contraindicated

13. Radiation Dose Comparison

ExaminationApproximate Dose
CAC scoring1–2 mSv
Coronary CT angiography3–15 mSv
Standard chest X-ray0.05–0.1 mSv
Annual background radiation~2.4 mSv

Summary

FeatureDetail
Scan typeNon-contrast, ECG-gated CT
ContrastNone required
TargetCoronary artery calcification
Primary scoreAgatston score
Threshold≥ 130 HU, ≥ 1 mm²
Slice thickness2.5–3 mm
Radiation dose~1–2 mSv
Main indicationIntermediate-risk asymptomatic adults
Key limitationDoes not assess non-calcified (soft) plaque

Sources:
  • Harrison's Principles of Internal Medicine, 22nd Ed. (2025), Ch. 248 & 284
  • Goldman-Cecil Medicine, International Ed., Ch. 44
  • Grainger & Allison's Diagnostic Radiology, Ch. 15
  • Fuster and Hurst's The Heart, 15th Ed., Ch. 21

Now ct perfusion scanning in detail as u give above , and also add diagram that I can draw in exam

Finding Sources
Finding Sources
Searching Images

CT perfusion brain cerebral blood flow CBF CBV MTT map

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Finding Sources
Reading File
Reading File
Generating Image
Here is the comprehensive breakdown:

CT Perfusion Scanning (CTP) — In Detail


1. Definition

CT Perfusion (CTP) is a dynamic, contrast-enhanced CT technique that provides quantitative maps of tissue haemodynamics by tracking the first-pass passage of an iodinated contrast bolus through the brain (or any organ) over time. It generates colour-coded parametric maps of cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT), and time-to-maximum (Tmax), which allow differentiation of irreversibly infarcted tissue (core) from potentially salvageable ischaemic tissue (penumbra).
"CT perfusion scans generate quantitative color maps that indicate various physiologic parameters such as cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT) through quantitative analysis of rapidly acquired image sequences during intravenous contrast administration." — Schwartz's Principles of Surgery

2. Principle

Physiological Basis

Normal CBF is 50–55 mL/100 g brain tissue/min. When cerebral perfusion pressure (CPP) drops, the brain autoregulates by:
  1. Vasodilation → increases CBV, maintains CBF
  2. Blood cells spend longer in the tissue → MTT prolongs
  3. If vessels are maximally dilated and CPP drops further → CBF falls
  4. Oxygen extraction increases maximally, then cellular dysfunction begins
  5. When CBF < 15–20 mL/100g/min → loss of electrical neuronal function
  6. When CBF < 10 mL/100g/min → ATP failure → Na⁺/K⁺ pump failure → cytotoxic oedema → irreversible infarction

The Penumbra Model

Following thromboembolic occlusion, three concentric zones form:
ZoneCBFCell Status
Infarct core< 10 mL/100g/minDead — irreversible
Ischaemic penumbra10–20 mL/100g/minAlive but dysfunctional — salvageable
Benign oligaemia20–50 mL/100g/minMildly reduced — will survive
The penumbra is the therapeutic target — reperfusion saves it; delay causes it to recruit into the core.

Physical / Mathematical Principle

CTP uses the indicator-dilution (tracer kinetic) model:
  1. A bolus of iodinated contrast is injected IV
  2. The contrast transiently increases CT attenuation (HU) as it passes through tissue
  3. Repeated CT acquisitions are made rapidly over the same slices — generating a time-density curve (TDC) at every pixel
  4. Two curves are generated: the arterial input function (AIF) from a large artery, and the tissue curve from brain parenchyma
From these curves, by mathematical deconvolution:
ParameterDerived FromRepresents
CBVArea under the tissue curve (relative to AIF)Volume of blood per 100g tissue (mL/100g)
CBFGradient / peak of deconvolved residue functionFlow of blood per 100g tissue per minute (mL/100g/min)
MTTCentral volume principle: MTT = CBV ÷ CBFAverage transit time of blood through tissue (seconds)
TmaxTime to maximum of residue functionDelay between AIF and tissue bolus arrival — best marker of penumbra
TTPTime from injection to peak enhancementSimpler, no AIF deconvolution needed

3. Key Parameters — Normal Values and Significance

ParameterNormal ValueIn PenumbraIn Core Infarct
CBF50–55 mL/100g/min↓ (10–20)↓↓ (< 10)
CBV4–6 mL/100gPreserved or ↑↓ (microvascular collapse)
MTT4–6 secondsProlonged ↑Very prolonged
Tmax< 6 seconds> 6 s (penumbra threshold)> 10 s
TTPShortDelayedVery delayed
Key rule:
  • Core = CBF severely reduced AND CBV reduced (microvascular collapse)
  • Penumbra = CBF moderately reduced BUT CBV preserved (autoregulation still working)
  • Mismatch = Penumbra volume ≥ 20% larger than core → favourable for reperfusion therapy

4. Exam Diagram

CT Perfusion Workflow Diagram

How to Draw in Exam — Step by Step

Draw 4 boxes arranged vertically:
Box 1 — Time-Density Curve:
HU
↑        AIF (tall, sharp peak)
|       /\
|      /  \      Tissue curve (low, broad)
|    /    \   /‾‾‾\
|  /      \_/      \___
+________________________→ Time (sec)

Area under tissue curve = CBV
Peak height / steepness = related to CBF
MTT = CBV ÷ CBF
Box 2 — Four Perfusion Maps (axial brain outline):
Draw 4 simple oval brain outlines side by side, labeled:
  • CBF → dark hole on one side (reduced)
  • CBV → smaller hole (core only reduced; penumbra preserved)
  • MTT → large bright/prolonged area
  • Tmax → largest area of delay (>6s = penumbra threshold)
Box 3 — Concentric Circles (Penumbra Model):
         Benign oligaemia (CBF 20-50)
       ┌──────────────────────────┐
       │   Ischaemic penumbra     │
       │    ┌──────────────┐      │
       │    │  INFARCT     │      │
       │    │    CORE      │      │
       │    │ CBF < 10     │      │
       │    └──────────────┘      │
       │     CBF 10–20            │
       └──────────────────────────┘
              CBF 20–50
Box 4 — Mismatch Concept:
|████████████████████████| ← Penumbra volume
|████████|                ← Core volume
         ↑
    Mismatch ratio ≥ 1.8 → TREAT (thrombectomy/thrombolysis)

5. CTP Perfusion Maps — Clinical Images

Acute left MCA territory stroke — TTP, MTT, CBF, CBV maps:
TTP MTT CBF CBV perfusion maps acute stroke
Large red area on TTP and MTT (left MCA territory) = delayed perfusion. CBF markedly reduced. CBV relatively preserved = classic ischaemic penumbra pattern. This is a favourable mismatch — candidate for thrombectomy.
Normal post-treatment CTP — all 5 maps:
Normal CTP showing CBV TTP CBF MTT Delay maps
Post-stenting follow-up showing symmetrical, normal perfusion across all maps.

6. Equipment Required

CT Scanner

  • Multi-detector CT (MDCT) — minimum 64-slice; optimal 128-slice or higher
  • Wide-detector CT (256–320 slice) — covers the entire brain in a single rotation without table movement; reduces radiation and motion artefact (preferred)
  • Older systems required toggling (shuttling) the table back and forth to cover the whole brain
  • Modern photon-counting CT — improved resolution and reduced dose

Contrast Injector

  • Dual-head power injector — delivers contrast at precise rate (typically 4–6 mL/sec) followed by saline flush
  • Required for tight, reproducible bolus

Monitoring

  • ECG monitoring (not mandatory but useful if arrhythmia suspected)
  • Pulse oximetry and IV access

Post-Processing Software

  • Dedicated perfusion workstation software (e.g., Syngo.via [Siemens], IntelliSpace [Philips], Advantage Workstation [GE], RAPID [iSchemaView] — the most validated for stroke)
  • Software performs:
    • Automated AIF selection
    • Deconvolution algorithms
    • Colour map generation
    • Core vs. penumbra segmentation
    • Mismatch ratio calculation

7. Indications

Neurological (Primary — Brain CTP)

  1. Acute ischaemic stroke — most important indication
    • Identify ischaemic core vs. salvageable penumbra
    • Guide decision for IV thrombolysis (tPA) and mechanical thrombectomy
    • Extended time window (6–24 hours) — patient selection by DAWN/DEFUSE-3 criteria
  2. Transient ischaemic attack (TIA) — detect occult hypoperfusion
  3. Vasospasm after subarachnoid haemorrhage — assess delayed cerebral ischaemia
  4. Brain tumours — assess vascularity, grade, distinguish recurrence from radiation necrosis
  5. Pre-surgical cerebrovascular reserve assessment

Non-Neurological Uses

  • Acute pancreatitis — detect pancreatic necrosis earlier than conventional CT
  • Oncology — assess tumour perfusion, angiogenesis, treatment response (lung, liver, pancreas)
  • Pulmonary nodules — differentiate malignant from benign

8. Patient Preparation

  1. IV access — large-bore antecubital vein (18G or larger), right arm preferred (avoids left brachiocephalic vein artefact on CTA)
  2. Assess renal function — eGFR > 30 mL/min/1.73m² preferred; in acute stroke, benefit usually outweighs risk
  3. Contrast allergy history — premedication if previous mild reaction; avoid if severe prior anaphylaxis
  4. Metformin — hold for 48 hours after contrast if eGFR < 60
  5. Establish IV line patency — extravasation must be avoided (high injection rate)
  6. Explain procedure — reassure regarding warmth/flushing sensation from contrast
  7. Patient lies supine and still — head in headrest/immobiliser
  8. No breath-hold required (unlike cardiac CT) — the brain does not move with breathing

9. Scan Protocol — Step by Step

Step 1: Non-Contrast CT (NECT)

  • Standard axial NECT of the brain first — mandatory
  • Purpose: exclude haemorrhage before contrast, assess ASPECTS score, identify hyperdense vessel sign
  • Parameters: 120 kVp, standard dose, 5mm slices, brain/bone window

Step 2: CT Angiography (CTA)

  • Performed as part of multimodal CT in most acute stroke protocols
  • Contrast bolus (60–80 mL at 4–5 mL/sec) with bolus tracking trigger on aortic arch
  • Covers arch of aorta to vertex — assesses for large vessel occlusion (LVO)

Step 3: CT Perfusion Acquisition

Contrast injection parameters:
ParameterValue
Contrast volume40–50 mL
Injection rate4–6 mL/sec
Saline flush30–40 mL at same rate
Contrast concentration300–400 mgI/mL
CT acquisition parameters:
ParameterValue
Scan delay4–6 seconds post-injection start
Scan duration40–60 seconds of dynamic acquisition
Tube voltage80–100 kVp (lower = better iodine contrast)
Tube current100–200 mA (low dose)
Rotation time0.5 sec
Slice thickness5–10 mm (brain CTP)
Coverage80–160 mm (wide-detector CT: whole brain)
ModeToggling or fixed-table depending on scanner
Frame rate1 image/second per location

Step 4: Image Acquisition Sequence

Inject contrast IV (4-6 mL/sec)
        ↓
Start CT acquisition at 4-6 sec delay
        ↓
Repeated CT passes over same brain levels
  → every 1-2 seconds for 40-60 seconds
        ↓
Generates ~40-60 time-points per level
        ↓
Time-density curve built for every pixel

Step 5: Post-Processing

  1. Motion correction — automated realignment of all time-point images
  2. Vessel identification — AIF selected (usually MCA or ACA), venous output function (VOF) selected from superior sagittal sinus
  3. Deconvolution — mathematical calculation of CBF, CBV, MTT, Tmax for every pixel
  4. Threshold application — software applies validated thresholds:
    • Core: CBF < 30% of contralateral (or CBF < 10 mL/100g/min)
    • Penumbra: Tmax > 6 seconds
  5. Colour map generation — colour-coded parametric maps displayed
  6. Mismatch calculation — penumbra volume ÷ core volume → mismatch ratio

Step 6: Reporting

Report must include:
  • Core infarct volume (mL)
  • Penumbra volume (mL)
  • Mismatch ratio and mismatch volume
  • Presence/absence of large vessel occlusion (from CTA)
  • Any haemorrhagic transformation
  • Collateral flow assessment

10. Stroke Treatment Criteria Using CTP (DAWN / DEFUSE-3)

CriteriaValue
Core infarct volume (6–16 hr)≤ 70 mL
Core-penumbra mismatch volume≥ 15 mL
Mismatch ratio≥ 1.8
Tmax threshold for penumbra> 6 seconds
Core infarct (16–24 hr)≤ 70 mL (DAWN)
"CT perfusion within 6–16 hr: core infarct volume ≤70 mL, core-penumbra mismatch volume ≥15 mL, core-penumbra mismatch ratio ≥1.8" — Washington Manual of Medical Therapeutics

11. Radiation Dose

ComponentApproximate Dose
NECT brain1–2 mSv
CTP alone3–8 mSv
Full multimodal CT (NECT + CTA + CTP)5–12 mSv
Wide-detector scanners and low-kVp protocols significantly reduce CTP dose.

12. Limitations and Pitfalls

LimitationDetail
Motion artefactPatient head movement degrades maps — motion correction algorithms partially compensate
AIF selection errorIncorrect AIF placement leads to systematic errors in all maps
Limited brain coverage (older scanners)Toggling misses the full brain; wide-detector CT solves this
Contrast contraindicationsRenal failure, allergy
Tmax sensitivity to AIFSmall AIF shape variations alter Tmax maps significantly
Does not show non-perfusion causesMetabolic, toxic, or ictal causes of deficits may mimic perfusion abnormality
Threshold variabilityDifferent platforms use different CBF/CBV thresholds — limit inter-institution comparison
Not for haemorrhagic strokeContrast contraindicated in active large haemorrhage

13. Comparison of CT Perfusion vs. MR Perfusion

FeatureCTPMR Perfusion (PWI)
SpeedFast (~1 min)Slower
AvailabilityWidely availableLess available acutely
RadiationYes (3–8 mSv)No
ContrastIodinatedGadolinium
Sensitivity to haemorrhageGood (NECT done first)Better (SWI/GRE)
Motion artefactLess susceptibleMore susceptible
Spatial resolutionSlightly lowerHigher
Core markerCBF < 30% or CBV reducedDWI
Penumbra markerTmax > 6 secTmax > 6 sec (PWI)

14. Summary Table

FeatureDetail
Scan typeDynamic contrast-enhanced CT
ContrastIodinated IV, 40–50 mL at 4–6 mL/sec
Duration of dynamic scan40–60 seconds
Primary mapsCBF, CBV, MTT, Tmax
Core thresholdTmax > 10s or CBF < 30% contralateral
Penumbra thresholdTmax > 6 seconds
Mismatch for treatmentRatio ≥ 1.8, volume ≥ 15 mL
Main clinical indicationAcute ischaemic stroke
Radiation dose3–8 mSv
Key formulaMTT = CBV ÷ CBF

Sources:
  • Grainger & Allison's Diagnostic Radiology, Ch. 56 (Acute Stroke Imaging)
  • Harrison's Principles of Internal Medicine, 22nd Ed., Ch. 434
  • Schwartz's Principles of Surgery, 11th Ed., Ch. 42
  • Washington Manual of Medical Therapeutics
  • Rosen's Emergency Medicine, Ch. 14

Myocardial imaging in detail in ct ?

Finding Sources
Finding Sources
Searching Images

myocardial CT imaging cardiac perfusion late enhancement viability

Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Searching Images

cardiac CT myocardial perfusion stress adenosine short axis LV defect

Loading Image
Reading File
Generating Image

Myocardial Imaging in CT — In Detail


1. Overview and Definition

Myocardial CT imaging refers to the use of ECG-gated, contrast-enhanced multi-detector CT (MDCT) to evaluate the myocardium in terms of:
  1. Morphology and structure — wall thickness, mass, volume
  2. Global and regional systolic function — ejection fraction, wall motion
  3. Myocardial perfusion — stress CT perfusion (CTP), detection of ischaemia
  4. Myocardial viability and tissue characterisation — infarct, fibrosis, oedema
  5. Physiological significance of stenosis — CT-derived FFR (FFR-CT)
"Stress CT myocardial perfusion may be used for evaluating myocardial perfusion for the detection of functionally significant coronary artery disease." — Grainger & Allison's Diagnostic Radiology
"Evolving new applications for the adjudication of the hemodynamic significance of stenosis such as CT myocardial perfusion imaging and FFR-CT are now being used in clinical practice." — Fuster and Hurst's The Heart, 15th Ed.

2. Why CT for Myocardial Imaging?

Cardiac CT with ≥64-slice MDCT offers:
  • Excellent spatial resolution (< 0.5 mm in-plane) — superior to nuclear or echo
  • True 3D volumetric dataset — any plane can be reconstructed
  • Fast acquisition — full heart in 5–15 seconds
  • Ability to combine anatomy (CCTA) + perfusion (CTP) + function in a single session
  • Limitation: ionising radiation, iodinated contrast, heart rate dependency

3. Exam Diagram

Myocardial CT Imaging Exam Diagram

MODULE A: CT Assessment of Ventricular Morphology and Function

3A.1 Acquisition Requirements

  • ECG-gated MDCT — mandatory to freeze cardiac motion
  • Two acquisition modes:
ModeDescriptionUse
Prospective ECG triggeringImages acquired at one fixed phase (~75% R-R, mid-diastole)Coronary anatomy; low dose ~2–5 mSv
Retrospective ECG gatingContinuous helical acquisition throughout entire cardiac cycle; any phase reconstructableVentricular function, wall motion; higher dose 12–21 mSv; dose modulation reduces this
  • For LV function alone: low-dose cine CT throughout cardiac cycle suffices
  • Iodinated contrast is required (except for CAC scoring)

3A.2 Standard Reconstructed Views

The 17-segment AHA model of the LV is used — same as nuclear/echo/CMR:
Short-axis views (basal, mid, apical):
Each ring divided into 6 (basal/mid) or 4 (apical) segments
+ Apex = segment 17

Coronary territory assignment:
  LAD  → anterior, anteroseptal, apical segments
  RCA  → inferior, inferoseptal segments
  LCx  → lateral, inferolateral segments
Standard CT planes used:
  • Short-axis (SA) — most important; perpendicular to LV long axis
  • Two-chamber (vertical long axis)
  • Four-chamber (horizontal long axis)
  • Three-chamber (LV outflow tract view)

3A.3 Ventricular Volume and Ejection Fraction

From retrospectively gated data:
  • End-diastolic volume (EDV) and end-systolic volume (ESV) are measured from contoured endocardial borders
  • EF = (EDV − ESV) ÷ EDV × 100
  • CT is highly accurate for volumetric analysis — more so than 2D echo
  • LV mass = (epicardial volume − endocardial volume) × myocardial density (1.05 g/mL)

3A.4 Regional Wall Motion Assessment

  • From functional cine reconstruction, systolic wall thickening and inward endocardial motion are assessed per segment
  • Wall motion abnormalities (hypokinesis, akinesis, dyskinesis) in a coronary distribution = ischaemic aetiology
  • Ventricular thinning + wall motion abnormality = scar / prior MI

MODULE B: CT Myocardial Perfusion Imaging (CT-MPI / CTP)

3B.1 Principle

CTP assesses first-pass myocardial contrast enhancement — regions supplied by stenosed coronary arteries show lower HU (hypoattenuation) during pharmacological stress compared to normally perfused myocardium.
The physiological basis:
  • A coronary stenosis may not limit blood flow at rest (autoregulation compensates)
  • Pharmacological vasodilators (adenosine, dipyridamole, regadenoson) maximally dilate normal microvessels → increase flow in normal territories 3–5× above baseline
  • Stenosed arteries cannot match this → relative hypoperfusion = perfusion defect appears on CT as hypoattenuation

3B.2 Two Types of CT Perfusion

TypeDescription
Static CTP (single phase)One image at peak contrast enhancement during stress → detects relative hypoattenuation; simpler, lower dose
Dynamic CTPSerial CT acquisitions over time during contrast bolus → generates quantitative parametric maps of MBF (mL/min/g); similar to brain CTP

3B.3 Protocol

Two separate CT acquisitions are required:
Step 1: Rest CCTA (coronary CT angiography)
           ↓
        10–30 minute washout interval
        (allow contrast to clear + vasodilator to wear off)
           ↓
Step 2: Pharmacological stress
        → Adenosine 140 µg/kg/min IV × 3 min, OR
        → Regadenoson 0.4 mg IV bolus
           ↓
Step 3: IV contrast (40–60 mL at 5 mL/sec) injected
           ↓
Step 4: Stress CTP acquisition during peak myocardial enhancement
        → Timed bolus tracking or fixed delay (~30 sec post-injection)
           ↓
Step 5: Post-processing — short-axis colour maps generated
        → Perfusion defect = dark area (↓ HU) during stress
        → Normal myocardium = bright (↑ HU)

3B.4 Acquisition Parameters for Stress CTP

ParameterValue
kVp80–100 kVp (lower = better iodine contrast)
mAs200–400 (higher than rest for SNR)
GatingProspective ECG triggering
Coverage80–160 mm (wide detector) or table toggle (older scanners)
Slice thickness0.6–1.5 mm reconstructed
Heart phaseEnd-diastole (~75% R-R)
Rotation time0.25–0.35 sec
Radiation dose~3–5 mSv (static); ~5–8 mSv (dynamic)

3B.5 Image Interpretation

Perfusion defect = area of hypoattenuation (dark) in myocardium during stress, compared to normally enhancing myocardium:
FindingInterpretation
Stress defect only (reversible)Inducible ischaemia — viable but jeopardised myocardium
Stress + rest defect (fixed)Prior MI / scar (non-viable)
No defect (normal)No flow-limiting stenosis
Subendocardial defectMore common; subendocardium most vulnerable to ischaemia
Transmural defectFull-thickness infarction
Stress CTP — Rest vs Stress short-axis cardiac CT showing anteroseptal perfusion defect
Panel A (Rest): Normal uniform myocardial enhancement. Panel C (Stress): Distinct hypoattenuation (yellow arrow) in anteroseptal wall — inducible perfusion defect. Panels B and D: Segmentation overlay with epicardial (green) and endocardial (red) borders.
CT perfusion colour maps:
CT-MPI colour maps showing perfusion deficit in inferolateral wall with MRI LGE correlation
Panel a–c: Short-axis CT perfusion colour maps showing a large hypoperfused defect (dark blue-green) in the inferolateral wall, best delineated after motion correction and spatio-temporal filtering (c). Panel d: Corresponding MRI LGE confirms transmural infarction in same territory — excellent anatomical correlation.

MODULE C: FFR-CT (CT-Derived Fractional Flow Reserve)

3C.1 Definition and Principle

FFR-CT is a post-processing technique that uses standard resting CCTA images (no additional acquisition or pharmacological stress needed) and applies computational fluid dynamics (CFD) modelling to calculate the haemodynamic significance of a coronary stenosis.
Fractional Flow Reserve (FFR) = Pd / Pa
  • Pa = aortic (coronary inlet) pressure
  • Pd = distal coronary pressure beyond the stenosis
  • Normal FFR = 1.0; haemodynamically significant stenosis = FFR ≤ 0.80

3C.2 How FFR-CT Works

Standard resting CCTA
         ↓
Coronary artery segmentation (automated)
         ↓
3D mesh model of coronary tree built
         ↓
Computational fluid dynamics applied:
  → Patient-specific microvascular resistance assigned
  → Hyperaemic conditions simulated mathematically
         ↓
Pressure gradient calculated at every point
         ↓
FFR displayed as colour map along coronary tree
  Red/orange = FFR ≤ 0.80 (ischaemia-causing)
  Green = FFR > 0.80 (non-significant)

3C.3 Performance Data

Three landmark trials validated FFR-CT against invasive FFR:
TrialFinding
DISCOVER-FLOWFFR-CT more accurate than CTA alone for lesion-specific ischaemia
DeFACTOImproved per-vessel diagnostic accuracy over CTA
NXTPer-vessel accuracy: AUC 0.90 for FFR-CT vs 0.81 for CTA alone
PLATFORM Trial: FFR-CT used as gatekeeper to invasive coronary angiography (ICA):
  • Nonobstructive CAD found in only 12% of FFR-CT guided patients who proceeded to ICA vs 73% in standard care
  • 61% of CCTA/FFR-CT patients had ICA cancelled with no adverse events
  • Significantly less expensive and better QoL improvement

3C.4 When to Use FFR-CT

  • Intermediate coronary stenosis on CCTA (40–70% stenosis) where functional significance is unclear
  • Avoids need for invasive angiography or stress testing
  • Particularly useful for 50–69% stenoses where CTA alone performs poorly

MODULE D: Myocardial Tissue Characterisation by CT

3D.1 CT Myocardial Infarction Detection

On contrast-enhanced CCTA or delayed CT:
FindingCT AppearanceSignificance
Acute MIHypoattenuation (dark) in myocardium during arterial phaseReduced perfusion in infarcted zone
Chronic MI / ScarMyocardial thinning (< 6 mm) + hypoattenuationFull-thickness scar; non-viable
Microvascular obstructionPersistent dark core after contrast — "no-reflow"Worst prognosis after MI
Late iodine enhancement (LIE)Hyperattenuation on 10-min delayed CT (analogous to LGE-CMR)Extracellular iodine accumulation in fibrosis/scar
Late Iodine Enhancement (LIE):
  • Iodinated contrast behaves similarly to gadolinium in infarcted tissue
  • In scarred/fibrotic myocardium, extracellular space is expanded → contrast pools → delayed hyperattenuation on CT at 5–15 minutes post-injection
  • Subendocardial LIE in a coronary distribution = ischaemic scar (analogous to LGE-CMR)
  • Transmural LIE = extensive infarction

3D.2 CT Appearance of Myocardial Conditions

ConditionCT Finding
Normal myocardiumUniform 80–100 HU after contrast
Acute ischaemia / infarctionSubendocardial or transmural hypoattenuation (dark wedge)
Chronic MI / scarThinned wall (< 6 mm), hypoattenuation; ± LIE
LV aneurysmDyskinetic, thinned, bulging wall; ± thrombus (low HU)
ThrombusLow HU (20–40 HU), non-enhancing filling defect
Hypertrophic cardiomyopathy (HCM)Asymmetric LV hypertrophy; sigmoid septum; SAM
Dilated cardiomyopathyGlobal LV dilatation, thin walls, reduced EF
Cardiac amyloidDiffuse concentric thickening; subendocardial LIE
MyocarditisSubepicardial/mid-wall LIE in non-coronary distribution
Pericardial effusionLow-attenuation rim around heart; HU varies with content

3D.3 Myocardial Fat

  • Fat appears as very low HU (−50 to −100 HU) within myocardium
  • Seen in: lipomatous metaplasia of old infarct, arrhythmogenic right ventricular cardiomyopathy (ARVC), cardiac lipoma
  • ARVC: fatty replacement of RV free wall — CT highly sensitive

MODULE E: Cardiac CT for Structural Heart Disease

3E.1 Pre-TAVR CT Protocol

CT has become the primary imaging tool before TAVI (TAVR):
  • Aortic annulus measurement — true short-axis plane, measured in systole
    • Annular area, perimeter, short and long diameters
    • Used for prosthetic valve sizing
  • Aortic root anatomy — sinus of Valsalva dimensions, coronary ostia heights
  • Left ventricular outflow tract (LVOT) assessment
  • Iliofemoral access route assessment for catheter delivery
  • Calcium scoring of aortic valve and LVOT

3E.2 Other Structural Uses

IndicationCT Contribution
Pulmonary vein mapping (pre-AF ablation)Pulmonary vein anatomy, ostial diameters
Left atrial appendage (LAA) thrombusLAA filling defect (low HU) on CTA
Congenital heart diseaseAnomalous vessels, septal defects, complex anatomy
Cardiac masses / tumoursCharacterise location, density, vascularity, pericardial involvement
Pericardial diseaseThickness, calcification, effusion, constriction

MODULE F: Comparison of Cardiac CT with Other Modalities

ParameterCardiac CTCMR (MRI)EchocardiographyNuclear (SPECT/PET)
Coronary anatomyExcellentPoorPoorNone
LV volumes / EFExcellentGold standardGoodGood
Myocardial perfusionGood (CTP)Gold standardLimitedGood
Tissue characterisationModerate (LIE)Gold standard (LGE)PoorModerate
CalcificationExcellentPoorPoorNone
RadiationYes (2–12 mSv)NoneNoneYes (5–15 mSv)
ClaustrophobiaRare issueMajor issueNoneRare
Heart rate dependencyYesLessNoNo
Scan timeMinutes30–60 min20–30 min30–90 min

MODULE G: Protocols Summary — Complete Cardiac CT Study

A comprehensive one-stop cardiac CT examination typically includes:
StepScanPurposeContrast
1CAC scoringCardiovascular riskNone
2Rest CCTACoronary anatomy, plaqueYes
3FFR-CT (post-processing)Haemodynamic significanceSame images
4Stress CTPMyocardial perfusionYes (repeat)
5Delayed phase (5–15 min)LIE — infarct/scarSame contrast
6Functional analysisLV volumes, EF, wall motionFrom retrospective data

MODULE H: Radiation Dose Summary

ExaminationApproximate Dose
CAC scoring1–2 mSv
Prospective CCTA2–5 mSv
Retrospective CCTA (with function)8–15 mSv
Static stress CTP3–5 mSv
Dynamic stress CTP5–8 mSv
Full one-stop (rest + stress)8–15 mSv total

Limitations of CT Myocardial Imaging

LimitationDetail
Heart rateMust be < 65 bpm for optimal coronary imaging; beta-blockers often required
Heavy calcificationBloom artefact obscures lumen; limits perfusion assessment
Irregular rhythm (AF)Motion artefact despite ECG gating
Iodinated contrastNephrotoxicity, allergy risk
RadiationCumulative dose concern; dose optimisation mandatory
Limited soft-tissue contrastLGE-CMR remains gold standard for tissue characterisation
Obese patientsImage noise, artefact; dual-source CT mitigates this
No real-time imagingUnlike echo, CT cannot assess haemodynamics dynamically

Summary Table

ApplicationTechniqueKey Finding
LV functionRetrospective ECG-gated CCTAEF, EDV, ESV, wall motion
Myocardial perfusion (ischaemia)Stress CTP (adenosine)Hypoattenuation defect on stress
FFR-CTCFD post-processing of CCTAFFR ≤ 0.80 = haemodynamically significant
Infarct/scarDelayed iodine enhancementSubendocardial/transmural LIE
Hypertrophy (HCM, amyloid)Contrast CCTAWall thickness > 15 mm
Pre-TAVRRetrospective ECG-gatedAnnulus sizing, vascular access
LAA thrombusCCTA + delayed phaseNon-enhancing LAA filling defect

Sources:
  • Grainger & Allison's Diagnostic Radiology, Ch. 12 & 15
  • Fuster and Hurst's The Heart, 15th Ed., Ch. 3 & 6
  • Harrison's Principles of Internal Medicine, 22nd Ed., Ch. 248
  • Goldman-Cecil Medicine, Ch. 44
This is a shared conversation. Sign in to Orris to start your own chat.